Lansoprazole Crescent Pharma (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the proton pump, on gastric parietal cells. This enzyme is the final step in the secretion of gastric acid. By irreversibly inhibiting the pump, lansoprazole markedly reduces acid production, allowing the gastrointestinal lining to heal and decreasing reflux symptoms.

The specific dose and dosing schedule for Lansoprazole Crescent Pharma are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals tailor the regimen to each individual, and patients should follow the prescriber’s instructions without deviation.

Safety data for Lansoprazole Crescent Pharma in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks to the fetus or infant. If treatment is deemed necessary, it should be used under medical supervision, and breastfeeding mothers should discuss any concerns with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details (including any cold‑chain needs), and assists with import documentation.

Lansoprazole belongs to the proton pump inhibitor (PPI) class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, lansoprazole has a similar efficacy profile but may differ slightly in metabolism and drug‑interaction potential, making individual patient factors important when selecting therapy.

Lansoprazole Crescent Pharma should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Lansoprazole Crescent Pharma is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the dose before a meal, often in the morning, unless the prescriber advises otherwise. Patients should not crush, chew, or split the tablet unless instructed.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, and significant electrolyte disturbances like low magnesium. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, persistent diarrhea, muscle cramps, or unexplained fatigue.

Lansoprazole Crescent Pharma is contraindicated in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Patients with severe liver disease, those taking medications that require an acidic environment for absorption, or those with a history of certain allergic reactions should discuss alternatives with their healthcare provider.